The Natural History and Biological Study of Pulmonary Recurrent Respiratory Papillomatosis (pRRP)
This study examines recurrent respiratory papillomatosis (RRP), a rare disease caused by human papillomavirus infection that affects about 20,000 Americans. Researchers will collect information about the natural progression of the disease and study its biological characteristics to better understand how it develops and affects patients over time.
Key Objective:This trial aims to advance scientific understanding of RRP through detailed biological study, which could eventually lead to improved treatment options for this understudied orphan disease.
Who to Consider:Patients diagnosed with recurrent respiratory papillomatosis who want to contribute to medical research that may help future patients with this rare condition should consider enrolling.
Trial Parameters
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
Brief Summary
Recurrent respiratory papillomatosis (RRP) is an orphan disease that affects approximately 20,000 people in the United States and is caused by infection with human papillomavirus (HPV) types 6 and 11. Since RRP is an orphan disease, it is an understudied disease entity with correspondingly few treatment options. The investigators hypothesize that by understanding the biology of RRP and the failed host immune responses against HPV, novel and rational therapies can be developed. This study will examine the genetic and immunologic alterations found in these rare tumors and distant metastatic involved sites (such as the lung) in patients diagnosed with RRP.
Eligibility Criteria
Inclusion Criteria: * History of HPV-associated Recurrent Respiratory Papillomatosis * Has pulmonary lesions Exclusion Criteria: * None